Adalimumab Therapy Achieves Clinical Remission and Response at Week 26 in Chinese Patients with Crohn's Disease

被引：1
|
作者：
Wu, Kai-Chun [1 ]
Ran, Zhi Hua [2 ]
Gao, Xiang [3 ]
Chen, Minhu [4 ]
Zhong, Jie [5 ]
Sheng, Jian-Qiu [6 ]
Kamm, Michael A. [7 ,8 ]
Travis, Simon [9 ,10 ]
Robinson, Anne M.
Wallace, Kori
Shapiro, Marisa
Li, Yao
Thakkar, Roopal B.
机构：
[1] Fourth Mil Med Univ, Xijing Hosp, Xian, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Renji Hosptial, Huangpu, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
[5] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai, Peoples R China
[6] Beijing PLA, Mil Gen Hosp, Beijing, Peoples R China
[7] St Vincents Hosp Melbourne, Parkville, Vic, Australia
[8] Univ Melbourne, Parkville, Vic, Australia
[9] John Radcliffe Hosp, Oxford, England
[10] AbbVie Inc, N Chicago, IL USA
来源：
INFLAMMATORY BOWEL DISEASES | 2016年 / 22卷
关键词：
D O I：
10.1097/01.MIB.0000480212.77049.85
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P-107
引用
收藏
页码：S43 / S43
页数：1
相关论文
共 50 条
  • [1] Adalimumab Therapy Achieves Clinical Remission and Response at Week 26 in Chinese Patients With Crohn's Disease
    Wallace, Kori
    Wu, Kai-Chun
    Ran, Zhi Hua
    Gao, Xiang
    Chen, Minhu
    Zhong, Jie
    Sheng, Jian-Qiu
    Kamm, Michael
    Travis, Simon
    Robinson, Anne
    Shapiro, Marisa
    Li, Yao
    Thakkar, Roopal
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S796 - S796
  • [2] Adalimumab induction therapy achieves clinical remission and response in chinese patients with Crohn's Disease
    Wu, K. -C.
    Ran, Z. H.
    Gao, X.
    Chen, M.
    Zhong, J.
    Sheng, J. -Q.
    Kamm, M. A.
    Travis, S.
    Robinson, A. M.
    Wallace, K.
    Shapiro, M.
    Li, Y.
    Thakkar, R. B.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S277 - S277
  • [3] Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's disease
    Wu, Kai-Chun
    Ran, Zhi Hua
    Gao, Xiang
    Chen, Minhu
    Zhong, Jie
    Sheng, Jian-Qiu
    Kamm, Michael A.
    Travis, Simon
    Wallace, Kori
    Mostafa, Nael M.
    Shapiro, Marisa
    Li, Yao
    Thakkar, Roopal B.
    Robinson, Anne M.
    INTESTINAL RESEARCH, 2016, 14 (02) : 152 - 163
  • [4] Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial
    Colombel, Jean-Frederic
    Sandborn, William J.
    Rutgeerts, Paul
    Enns, Robert
    Hanauer, Stephen B.
    Panaccione, Remo
    Schreiber, Stefan
    Byczkowski, Dan
    Li, Ju
    Kent, Jeffrey D.
    Pollack, Paul F.
    GASTROENTEROLOGY, 2007, 132 (01) : 52 - 65
  • [5] Serum Adalimumab Concentration and Clinical Remission in Patients with Crohn's Disease
    Chiu, Yi-Lin
    Rubin, David T.
    Vermeire, Severine
    Louis, Edouard
    Robinson, Anne M.
    Lomax, Kathleen G.
    Pollack, Paul F.
    Paulson, Susan K.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (06) : 1112 - 1122
  • [6] Adalimumab for the induction and maintenance of clinical remission in Japanese patients with Crohn's disease
    Watanabe, Mamoru
    Hibi, Toshifumi
    Lomax, Kathleen G.
    Paulson, Susan K.
    Chao, Jingdong
    Alam, M. Shamsul
    Camez, Anne
    JOURNAL OF CROHNS & COLITIS, 2012, 6 (02): : 160 - 173
  • [7] Remission and clinical response to open label adalimumab over one year in patients with Crohn's disease
    Hanauer, SB
    Lukas, M
    Macintosh, DG
    Pollack, PF
    Kent, J
    GUT, 2006, 55 : A15 - A15
  • [8] Adalimumab maintains clinical remission and response in patients with active Crohn's disease: Results of the CHARM trial
    Sandborn, William J.
    Colombel, J. F.
    Rutgeerts, P.
    Enns, R.
    Hanauer, S. B.
    Panaccione, R.
    Schreiber, S.
    Lomax, K. G.
    Pollack, P. F.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S458 - S458
  • [9] Adalimumab maintenance therapy is cost effective for maintaining remission in patients with Crohn's disease
    Feagan, Brian
    Loftus, Edward
    Johnson, Scott
    Wu, Eric
    Yu, Andrew
    Chao, Jingdong
    Mulani, Parvez
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S383 - S383
  • [10] Post-Induction Adalimumab Drug Levels Predict Clinical and Laboratory Remission at Week 24 in Patients With Crohn's Disease
    Zittan, Eran
    Kelly, Orlaith
    Kabakchiev, Boyko
    Nguyen, Geoffrey C.
    Croitoru, Kenneth
    Steinhart, A. Hillary
    Silverberg, Mark S.
    GASTROENTEROLOGY, 2016, 150 (04) : S419 - S419
12345